SARA SCHWARTZBERG: Open Payments
NPI 1629675228 · ZACHARY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,297 in 118 payments from 18 companies in 2025. Trend: 2023 $374 · 2024 $950 · 2025 $2,297
Food & beverage: $2,218Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $744 |
| Lilly USA, LLC | 12 | $298 |
| GENZYME CORPORATION | 7 | $260 |
| Janssen Biotech, Inc. | 12 | $215 |
| PFIZER INC. | 12 | $170 |
| Incyte Corporation | 8 | $135 |
| Arcutis Biotherapeutics, Inc. | 4 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| Medtronic, Inc. | 1 | $64 |
| UCB, Inc. | 3 | $64 |
Products named: RINVOQ, DUPIXENT, SKYRIZI, TALTZ, TREMFYA, OPZELURA, CIBINQO, Zoryve.
Industry payments across LA — which companies pay providers there.
